drugset / Trial / NCT02096133
Vitamin D3 and the Stress-axis in MS
RandomizedParallel-groupQuadruple-blindOther
Summary
Patients with multiple sclerosis (MS) have an increased risk of developing a major depression. The investigators observed a protective effect of high vitamin D levels on the risk of depression in MS. This might be driven by the effect of vitamin D on the stress-axis. Therefore, the main goal of the present study is to assess whether high dose vitamin D supplementation results in a suppression of the stress-axis, as measured by decreased levels of cortisol.
Timeline
- Start
- 2014-10-13
- Primary completion
- 2016-11-07
- Completion
- 2016-11-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Cholecalciferol | Other / unclassified | 100 ug | — |